BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21046311)

  • 1. p53 abnormality and tumor invasion in patients with malignant astrocytoma.
    Momota H; Narita Y; Matsushita Y; Miyakita Y; Shibui S
    Brain Tumor Pathol; 2010 Oct; 27(2):95-101. PubMed ID: 21046311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.
    Watanabe K; Sato K; Biernat W; Tachibana O; von Ammon K; Ogata N; Yonekawa Y; Kleihues P; Ohgaki H
    Clin Cancer Res; 1997 Apr; 3(4):523-30. PubMed ID: 9815715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.
    Lang FF; Miller DC; Pisharody S; Koslow M; Newcomb EW
    Oncogene; 1994 Mar; 9(3):949-54. PubMed ID: 8108140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethnicity delineates different genetic pathways in malignant glioma.
    Chen P; Aldape K; Wiencke JK; Kelsey KT; Miike R; Davis RL; Liu J; Kesler-Diaz A; Takahashi M; Wrensch M
    Cancer Res; 2001 May; 61(10):3949-54. PubMed ID: 11358811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of 1p/19q status by fluorescence in situ hybridization assay: A comparative study in oligodendroglial, mixed oligoastrocytic and astrocytic tumors.
    Shukla B; Agarwal S; Suri V; Pathak P; Sharma MC; Gupta D; Sharma BS; Suri A; Halder A; Sarkar C
    Neurol India; 2009; 57(5):559-66. PubMed ID: 19934553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.
    Ständer M; Peraud A; Leroch B; Kreth FW
    Cancer; 2004 Sep; 101(5):1028-35. PubMed ID: 15329912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas.
    Peraud A; Kreth FW; Wiestler OD; Kleihues P; Reulen HJ
    Clin Cancer Res; 2002 May; 8(5):1117-24. PubMed ID: 12006527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
    Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
    Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic analysis of p53 intratumoral heterogeneity in human astrocytic brain tumors.
    Ren ZP; Olofsson T; Qu M; Hesselager G; Soussi T; Kalimo H; Smits A; Nistér M
    J Neuropathol Exp Neurol; 2007 Oct; 66(10):944-54. PubMed ID: 17917588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses.
    Tada M; Iggo RD; Waridel F; Nozaki M; Matsumoto R; Sawamura Y; Shinohe Y; Ikeda J; Abe H
    Mol Carcinog; 1997 Mar; 18(3):171-6. PubMed ID: 9115587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult grade II diffuse astrocytomas are genetically distinct from and more aggressive than their paediatric counterparts.
    Jones DT; Mulholland SA; Pearson DM; Malley DS; Openshaw SW; Lambert SR; Liu L; Bäcklund LM; Ichimura K; Collins VP
    Acta Neuropathol; 2011 Jun; 121(6):753-61. PubMed ID: 21327941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of gemistocytes in astrocytoma progression.
    Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H
    Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterozygosity status of 1p and 19q and its correlation with p53 protein expression and EGFR amplification in patients with astrocytic tumors: novel series from India.
    Jha P; Agarwal S; Pathak P; Srivastava A; Suri V; Sharma MC; Chosdol K; Srivastava T; Gupta D; Gupta A; Suri A; Sarkar C
    Cancer Genet Cytogenet; 2010 Apr; 198(2):126-34. PubMed ID: 20362227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
    Fults D; Brockmeyer D; Tullous MW; Pedone CA; Cawthon RM
    Cancer Res; 1992 Feb; 52(3):674-9. PubMed ID: 1346255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TP53 mutations in malignant astrocytomas.
    Biernat W; Debiec-Rychter M; Kordek R; Liberski PP
    Pol J Pathol; 1997; 48(4):221-4. PubMed ID: 9529927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypes.
    Seiz M; Tuettenberg J; Meyer J; Essig M; Schmieder K; Mawrin C; von Deimling A; Hartmann C
    Acta Neuropathol; 2010 Aug; 120(2):261-7. PubMed ID: 20514489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of the TP53 gene in human gliomas.
    Rasheed BK; McLendon RE; Herndon JE; Friedman HS; Friedman AH; Bigner DD; Bigner SH
    Cancer Res; 1994 Mar; 54(5):1324-30. PubMed ID: 8118823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An immunohistochemical study of the expression of the oncoprotein p53 in astrocytic gliomas of the cerebral hemispheres].
    Korshunov AG; Sycheva RV
    Arkh Patol; 1996; 58(6):37-42. PubMed ID: 9139592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase activity and alterations in telomere length in human brain tumors.
    Hiraga S; Ohnishi T; Izumoto S; Miyahara E; Kanemura Y; Matsumura H; Arita N
    Cancer Res; 1998 May; 58(10):2117-25. PubMed ID: 9605755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and mutation analysis of the p53 gene in astrocytoma.
    Hwang SL; Hong YR; Sy WD; Chai CY; Lin HJ; Howng SL
    J Formos Med Assoc; 1999 Jan; 98(1):31-8. PubMed ID: 10063271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.